Expansion and Facility Global expansion and the development of an Innovation Center in Camden create opportunities to offer collaboration on biobanking, lab equipment, shared spaces, and contract research services tailored to translational genomics and personalized medicine.

Biobank Leadership As a world-leading biobank with extensive sample distribution, there is a strong potential to upsell sample access programs, data services, and access to annotated cohorts for pharma, biotech, and academia seeking well-characterized materials.

Pharmacogenomics Coriell Life Sciences focuses on pharmacogenomics and clinical decision support; prospective sales can target providers and payers with Corigen medication-safety solutions, value-based pricing, and integration with existing EHR workflows.

Strategic Partnerships Recent collaborations with state economic development authorities and cancer research initiatives indicate openness to public-private partnerships, enabling joint grant-funded projects, shared infrastructure, and co-development opportunities.

Investment Momentum Significant capital outlays for the innovation center and lab facilities signal a buyers’ cycle and readiness for equipment modernization, contract research expansions, and professional services around genomics, biobanking, and iPSC research.